Hepatoprotection by Cyclosporin A in Experimental Hepatitis. Sorting Desensitization of the Mitochondrial Permeablility Transition Pore from Immunosuppression | Debio 025 | /

Home|Careers|Contact us

News

20.11.2008
Debiopharm and Aurigene sign licensing agreement for the development and commercialisation of Debio 0617, a novel inhibitor of an undisclosed oncology pathway
17.11.2008
Debiopharm and Pharmaleads sign license agreement for Debio 0827 or PL37 in treatment of chronic pain conditions

Hepatoprotection by Cyclosporin A in Experimental Hepatitis. Sorting Desensitization of the Mitochondrial Permeablility Transition Pore from Immunosuppression

Luca Nicolosi, Elena Palma, Maria Eugenia Soriano, Francesca Finetti, Grégoire Vuagniaux, Jean-Maurice Dumont, Cosima T. Baldari and Paolo Bernardi

31st FEBS Congress Molecules in Health and Disease -June 2006 - Istanbul/Turkey

pdf Abstract + Poster